Home > Boards > US Listed > Medical - Equipment > World Heart Corp. (WHRT)

With the Levacor VAD Bridge-to-Transplant (BTT) clinical study

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DonShimoda Member Profile
 
Followed By 19
Posts 758
Boards Moderated 0
Alias Born 11/10/09
160x600 placeholder
DonShimoda   Monday, 06/07/10 09:58:11 PM
Re: None
Post # of 63 
With the Levacor VAD Bridge-to-Transplant (BTT) clinical study underway, it's nice to see the company generating revenue. Based on the $556k booked in just the 1Q, it looks like their recovering around $185k per patient.

Currently the company has 3 medical centers participating but plans to bring on an additional 7 by the end of the summer which should result in more implants and greater revenue.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences